A detailed history of Two Sigma Investments, LP transactions in Axogen, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 26,393 shares of AXGN stock, worth $412,786. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,393
Holding current value
$412,786
% of portfolio
0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.52 - $14.69 $198,475 - $387,713
26,393 New
26,393 $370,000
Q1 2024

May 15, 2024

BUY
$6.63 - $10.69 $68,037 - $109,700
10,262 New
10,262 $82,000
Q2 2023

Aug 14, 2023

BUY
$8.5 - $10.38 $136,272 - $166,412
16,032 New
16,032 $146,000
Q4 2022

Feb 14, 2023

BUY
$9.44 - $13.09 $329,068 - $456,304
34,859 New
34,859 $347,000
Q2 2022

Aug 15, 2022

SELL
$6.99 - $10.0 $175,756 - $251,440
-25,144 Reduced 30.35%
57,700 $473,000
Q1 2022

May 16, 2022

SELL
$7.26 - $10.7 $278,304 - $410,173
-38,334 Reduced 31.63%
82,844 $658,000
Q4 2021

Feb 14, 2022

BUY
$8.8 - $16.0 $1.07 Million - $1.94 Million
121,178 New
121,178 $1.14 Million
Q3 2021

Nov 15, 2021

SELL
$15.23 - $21.72 $1.17 Million - $1.66 Million
-76,581 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$17.8 - $23.5 $464,473 - $613,209
-26,094 Reduced 25.41%
76,581 $1.66 Million
Q1 2021

May 17, 2021

BUY
$17.18 - $22.6 $858,295 - $1.13 Million
49,959 Added 94.77%
102,675 $2.08 Million
Q4 2020

Feb 16, 2021

BUY
$11.5 - $17.96 $461,334 - $720,483
40,116 Added 318.38%
52,716 $944,000
Q3 2020

Nov 16, 2020

SELL
$10.62 - $13.12 $649,944 - $802,944
-61,200 Reduced 82.93%
12,600 $147,000
Q2 2020

Aug 14, 2020

BUY
$7.35 - $10.81 $427,035 - $628,061
58,100 Added 370.06%
73,800 $682,000
Q1 2020

May 15, 2020

BUY
$8.38 - $17.34 $131,566 - $272,238
15,700 New
15,700 $163,000
Q4 2019

Feb 14, 2020

SELL
$11.18 - $18.6 $1.19 Million - $1.98 Million
-106,629 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$12.09 - $20.46 $409,633 - $693,225
33,882 Added 46.58%
106,629 $1.33 Million
Q2 2019

Aug 14, 2019

SELL
$18.5 - $25.47 $597,975 - $823,266
-32,323 Reduced 30.76%
72,747 $1.44 Million
Q1 2019

May 15, 2019

SELL
$14.62 - $22.13 $2.16 Million - $3.27 Million
-147,797 Reduced 58.45%
105,070 $2.21 Million
Q4 2018

Feb 14, 2019

BUY
$17.09 - $38.25 $4.05 Million - $9.07 Million
237,067 Added 1500.42%
252,867 $5.17 Million
Q3 2018

Nov 14, 2018

BUY
$34.05 - $55.9 $537,990 - $883,220
15,800 New
15,800 $582,000
Q2 2018

Aug 14, 2018

SELL
$36.15 - $52.5 $5.42 Million - $7.87 Million
-149,888 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$24.4 - $40.25 $3.24 Million - $5.34 Million
132,620 Added 768.01%
149,888 $5.47 Million
Q4 2017

Feb 14, 2018

SELL
$18.5 - $28.6 $366,300 - $566,280
-19,800 Reduced 53.42%
17,268 $489,000
Q3 2017

Nov 14, 2017

BUY
$14.65 - $19.35 $543,046 - $717,265
37,068
37,068 $717,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $661M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.